These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1477008)

  • 21. Outcome of pregnancy in women with thyroid carcinoma.
    Schlumberger M; De Vathaire F; Ceccarelli C; Francese C; Pinchera A; Parmentier C
    J Endocrinol Invest; 1995 Feb; 18(2):150-1. PubMed ID: 7629385
    [No Abstract]   [Full Text] [Related]  

  • 22. Conventional withdrawal of thyroid hormone before radioiodine therapy in differentiated thyroid carcinoma: how frequently are adequately raised TSH levels attained?
    McLaughlin CM; Hunter SJ; Bell PM; McCance DR; Sheridan B; Atkinson AB
    Clin Endocrinol (Oxf); 2008 Jul; 69(1):169-70. PubMed ID: 18042175
    [No Abstract]   [Full Text] [Related]  

  • 23. Therapeutic administration of 131I for differentiated thyroid cancer: radiation dose to ovaries and outcome of pregnancies.
    Garsi JP; Schlumberger M; Rubino C; Ricard M; Labbé M; Ceccarelli C; Schvartz C; Henri-Amar M; Bardet S; de Vathaire F
    J Nucl Med; 2008 May; 49(5):845-52. PubMed ID: 18413399
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-dose radioiodine treatment for differentiated thyroid carcinoma is not associated with change in female fertility or any genetic risk to the offspring.
    Bal C; Kumar A; Tripathi M; Chandrashekar N; Phom H; Murali NR; Chandra P; Pant GS
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):449-55. PubMed ID: 16095849
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiation safety precautions with 131iodine therapy.
    Greenfield LD; Herman MW; Patrick J
    Cancer Nurs; 1978 Oct; 1(5):379-84. PubMed ID: 250446
    [No Abstract]   [Full Text] [Related]  

  • 26. Recombinant humane thyrotropin (rhtSH) a new aid in the diagnosis and treatment of thyroid carcinoma with radio-iodine.
    Brans B; Gemmel F; De Winter O; Fiers T; De Roose J; Vermeersch H; Rubens R; Kaufman JM; Dierckx RA
    Acta Clin Belg; 2001; 56(5):316-20. PubMed ID: 11770226
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Non-surgical treatment of thyroid neoplasms].
    Klepp O
    Tidsskr Nor Laegeforen; 1975 Aug; 95(23):1287-90. PubMed ID: 1179338
    [No Abstract]   [Full Text] [Related]  

  • 28. Coming of age: recombinant human thyroid-stimulating hormone as a preparation for (131)i therapy in thyroid cancer.
    Robbins RJ; Pentlow KS
    J Nucl Med; 2003 Jul; 44(7):1069-71. PubMed ID: 12843222
    [No Abstract]   [Full Text] [Related]  

  • 29. Acta Oncologica Lecture. Present status of the use of recombinant human TSH in thyroid cancer management.
    Luster M
    Acta Oncol; 2006; 45(8):1018-30. PubMed ID: 17118833
    [No Abstract]   [Full Text] [Related]  

  • 30. The effect of Ginkgo biloba extract on genotoxic damage in patients with differentiated thyroid carcinoma receiving thyroid remnant ablation with iodine-131.
    Dardano A; Ballardin M; Caraccio N; Boni G; Traino C; Mariani G; Ferdeghini M; Barale R; Monzani F
    Thyroid; 2012 Mar; 22(3):318-24. PubMed ID: 22181338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical application of recombinant human thyroid-stimulating hormone in management of differentiated thyroid carcinoma].
    Liu B; Kuang A
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2012 Jun; 29(3):588-92. PubMed ID: 22826964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Letter: Thyroid cancer after iodine-131 therapy.
    McDougall IR
    JAMA; 1974 Jan; 227(4):438. PubMed ID: 4859683
    [No Abstract]   [Full Text] [Related]  

  • 33. [The advantage of lithium in association with iodine 131 in the treatement of functioning metastasis of the thyroid cancer (author's transl)].
    Brière J; Pousset G; Darsy P; Guinet
    Ann Endocrinol (Paris); 1974; 35(3):281-2. PubMed ID: 4463794
    [No Abstract]   [Full Text] [Related]  

  • 34. Lenvatinib - A multikinase inhibitor for radioiodine-refractory differentiated thyroid cancer.
    Hewett Y; Ghimire S; Farooqi B; Shah BK
    J Oncol Pharm Pract; 2018 Jan; 24(1):28-32. PubMed ID: 27856921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical experience with radioiodine treatment of differentiated thyroid carcinoma].
    Ikekubo K; Saiki Y; Jeong S; Yamaguchi H; Ito H; Hino M; Ishihara T; Waseda N; Mori T
    Kaku Igaku; 1986 Nov; 23(11):1625-32. PubMed ID: 3820853
    [No Abstract]   [Full Text] [Related]  

  • 36. [Conservative therapy of thyroid tumors ].
    Kuma K; Matsuzuka F
    Nihon Naika Gakkai Zasshi; 1990 Jul; 79(7):905-9. PubMed ID: 2230471
    [No Abstract]   [Full Text] [Related]  

  • 37. Role of 18F-FDG-PET and PET/CT imaging in thyroid cancer.
    Nanni C; Rubello D; Fanti S; Farsad M; Ambrosini V; Rampin L; Banti E; Carpi A; Muzzio P; Franchi R
    Biomed Pharmacother; 2006 Sep; 60(8):409-13. PubMed ID: 16891093
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radioiodine ablation and therapy in differentiated thyroid cancer under stimulation with recombinant human thyroid-stimulating hormone.
    Berg G; Lindstedt G; Suurküla M; Jansson S
    J Endocrinol Invest; 2002 Jan; 25(1):44-52. PubMed ID: 11883865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Approach to the patient with advanced differentiated thyroid cancer.
    Schlumberger M; Sherman SI
    Eur J Endocrinol; 2012 Jan; 166(1):5-11. PubMed ID: 21890651
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blood and bone marrow dosimetry in radioiodine therapy of differentiated thyroid cancer after stimulation with rhTSH.
    Lassmann M; Hänscheid H; Reiners C; Thomas SR
    J Nucl Med; 2005 May; 46(5):900-1; author reply 901. PubMed ID: 15872369
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.